Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.37M 2.08M 1.94M 1.78M 3.34M 229M 3.39M 22.99M 8.98M 112M 8.89M 8.7M 388M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.37M 2.96M 2.75M 2.53M 4.75M 325M 4.83M 32.71M 12.77M 159M 12.64M 12.37M 552M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
07-15 Cannabis Bioscience International Holdings Receives Texas License for Consumable Hemp Products CI
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-19 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
25-10-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
25-10-06 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
25-09-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
25-09-21 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
25-04-22 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
25-01-21 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
25-01-06 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
24-12-26 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
24-11-26 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
24-11-25 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
1 week+50.00%
3 months-25.00%
6 months-40.00%
Current year-40.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0.01
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 70 2019-12-18
Treasurer 61 2024-05-05
Corporate Secretary 66 2019-12-18
Director TitleAgeSince
Director/Board Member 70 2019-12-18
Director/Board Member 66 2019-12-18
Director/Board Member 61 2024-05-05
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+50.00%-25.00%-40.00% 2.41M
+1.07%-4.73%-3.96%+11.63% 46.35B
+0.25%+5.61%+404.21%+606.87% 40.13B
-0.27%+2.67%+10.54%+65.01% 36.33B
+0.35%-1.16%+7.11%-8.85% 34.6B
+3.14%+1.02%+3.72%+34.86% 26.77B
+0.47%-2.29% - - 16.66B
-0.73%+11.80%+37.49%+145.18% 16.91B
+0.42%-4.46%+4.80%+8.67% 13.05B
-2.68%-2.49%-1.27%-32.60% 13.05B
Average +0.20%+0.91%+48.63%+87.86% 24.38B
Weighted average by Cap. +0.46%+0.77%+76.79%+132.15%

Financials

2024 2025
Net sales 249K 219K 203K 187K 351K 24.03M 357K 2.42M 944K 11.78M 934K 914K 40.76M 303K 267K 248K 228K 427K 29.26M 434K 2.94M 1.15M 14.34M 1.14M 1.11M 49.63M
Net income -651K -573K -533K -489K -918K -62.89M -933K -6.33M -2.47M -30.83M -2.45M -2.39M -107M -549K -483K -449K -412K -773K -52.99M -786K -5.33M -2.08M -25.98M -2.06M -2.02M -89.89M
Net Debt 939K 827K 768K 705K 1.32M 90.69M 1.35M 9.12M 3.56M 44.46M 3.53M 3.45M 154M 1M 880K 818K 751K 1.41M 96.59M 1.43M 9.72M 3.79M 47.35M 3.76M 3.67M 164M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
26-07-24 US$0.000200 -.--% 749,600
26-07-23 US$0.000200 +100.00% 20,000
26-07-22 US$0.000100 -.--% 1,533,552
26-07-21 US$0.000100 -50.00% 80,010,100
26-07-20 US$0.000200 -.--% 80,030,564
  1. Stock Market
  2. Stocks
  3. CBIH Stock